VC-backed Glaukos Corp files for IPO
Laguna Hills, California-based Glaukos Corporation, a developer of treatments for glaucoma, has filed for an IPO. The number of shares that will be sold as well as the IPO's pricing terms have yet to be set. The company plans on trading the stock on the NYSE under the ticker symbol "GKOS." J.P. Morgan, BofA Merrill Lynch and Goldman, Sachs & Co are serving as the lead underwriters. Glaukos' backers include OrbiMed Advisors, Frazier Healthcare Ventures, InterWest Partners, Domain Associates, Fjord Ventures, Montreaux Equity Partners and Versant Ventures
13 May 2015•2 mins read
